Published in BMC Cardiovasc Disord on March 01, 2017
Inflammation in atherosclerosis. Nature (2002) 28.92
Inflammation and atherosclerosis. Circulation (2002) 20.77
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation (1975) 10.97
A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol (1983) 6.27
A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med (2009) 5.81
Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol (2012) 3.87
N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med (2005) 3.35
The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol (1987) 3.09
Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation (2007) 2.72
C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation (2005) 2.53
Incidence and prognostic implications of stable angina pectoris among women and men. JAMA (2006) 2.16
Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis (2012) 1.81
Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am Heart J (2011) 1.70
The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The Coronary Artery Disease in General Practice (CADENCE) Study. Arch Intern Med (2009) 1.33
Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein. Arch Intern Med (2008) 1.19
Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome. N Engl J Med (1975) 1.19
Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography. Am J Cardiol (2013) 1.02
Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate. Ren Fail (2003) 1.02
A biomarker panel for peripheral arterial disease. Vasc Med (2008) 1.01
Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina. Circulation (2005) 1.00
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Arterioscler Thromb Vasc Biol (2006) 1.00
Biomarkers of peripheral arterial disease. J Am Coll Cardiol (2010) 0.98
Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke (2011) 0.98
Beta 2-microglobulin: its significance and clinical usefulness. Ann Clin Lab Sci (1990) 0.96
Beta 2 microglobulin in multiple myeloma. Am J Hematol (1985) 0.96
Beta-2-microglobulin review: its relevance in clinical oncology. Med Pediatr Oncol (1980) 0.94
Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med (2003) 0.92
Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling. Genome Med (2010) 0.92
β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients. Scand J Clin Lab Invest (2011) 0.91
Salivary and serum beta2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjögren syndrome and Sjögren syndrome secondary to systemic lupus erythematosus. Clin Chim Acta (2003) 0.90
Dialysis-related amyloidosis of the heart in long-term hemodialysis patients. Kidney Int Suppl (2001) 0.89
Beta-2 microglobulin in ESRD: an in-depth review. Adv Ren Replace Ther (2003) 0.89
Relationship of beta2-microglobulin to arterial stiffness in Japanese subjects. Hypertens Res (2005) 0.88
Antigen processing for presentation by MHC class I molecules. Curr Opin Immunol (1992) 0.84
Clinical significance of beta 2-microglobulin in serum of adult T cell leukemia. Leukemia (1995) 0.82
Beta 2-microglobulin levels in patients with renal insufficiency. Am J Kidney Dis (1989) 0.82
Circulating levels of β2-microglobulin and cystatin C are associated with left atrial size: additional link between the kidney and the heart. Clin Nephrol (2013) 0.81
Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis. Nephrology (Carlton) (2005) 0.79
Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels. Scand J Infect Dis (2000) 0.79
Associations of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rate. Curr Opin Nephrol Hypertens (2013) 0.78
Prognostic factors in multiple myeloma: role of beta 2-microglobulin and thymidine kinase. Clin Investig (1993) 0.77
Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes. Thromb Res (2013) 0.77